NEW YORK (GenomeWeb) – Accelerate Diagnostics' first quarter revenues dropped 13 percent year over year, the company said in a regulatory document on Friday.

In a Form 10-Q filed with the US Securities and Exchange Commission, the Tucson, Ariz.-based firm reported revenues of $14,000 for the three months ended March 31, compared to $16,000 in the year-ago quarter. Revenues for both quarters derived from licensing and royalty revenues.

The drop resulted from fluctuations in partner sales volumes, which affected Accelerate, it said in its SEC document.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: Leukemia-like disease in soft-shell clams, mNET-seq method for profiling growing transcripts, and more.

While James Watson and Francis Crick are credited for discovering the structure of DNA, Rich proved their theory of a double helix structure was correct when he produced a distinct image of the structure.

Nature News reports that early users of Oxford Nanopore's hand-held MinIon are giddy about the technology and its uses. 

According to MIT Technology Review, Apple is collaborating with researchers to develop apps for consumer DNA testing.